Literature DB >> 26546004

Local administration of gentamicin collagen sponge in surgical excision of sacrococcygeal pilonidal sinus disease: a systematic review and meta-analysis of the literature.

A L Nguyen1, A A Pronk1, E J B Furnée1, A Pronk1, P H P Davids1, N Smakman2.   

Abstract

Surgical site infections occur in up to 24 % of patients after surgical excision of sacrococcygeal pilonidal sinus disease with primary wound closure. Local administration of antibiotics by a gentamicin collagen sponge could reduce this infection rate. The objective of this systematic review and meta-analysis was to evaluate the effect of a gentamicin collagen sponge on outcome after surgical excision in patients with sacrococcygeal pilonidal sinus disease. A structured literature search was performed in the PubMed, Embase, The Cochrane Library, and Scopus databases. Studies comparing surgical excision of sacrococcygeal pilonidal sinus disease with versus without a gentamicin collagen sponge were included. Outcome measures were surgical site infection, wound healing, and recurrence. The search strategy yielded six studies with a total of 669 patients. Three randomized controlled trials, comparing excision of pilonidal sinus disease and primary wound closure with versus without gentamicin collagen sponge, were eligible for inclusion in the meta-analysis (319 patients), demonstrating a trend towards reduced surgical site infections after administration of gentamicin collagen sponge [absolute risk reduction 20 %, 95 %-confidence interval (CI) 1-41 %, p = 0.06]. The wound healing (absolute risk reduction 22 %, 95 % CI 32-77 %, p = 0.42) and recurrence rate (absolute risk reduction 8 %, 95 % CI 7-22 %, p = 0.30) were not significantly different between both groups. Administration of a gentamicin collagen sponge after surgical excision of sacrococcygeal pilonidal sinus disease showed no significant influence on wound healing and recurrence rate, but a trend towards a reduced incidence of surgical site infections. Therefore, additional larger well-designed randomized controlled trials are required.

Entities:  

Keywords:  Gentamicin sponge; Recurrence; Sacrococcygeal pilonidal sinus disease; Surgical site infection; Wound healing

Mesh:

Substances:

Year:  2015        PMID: 26546004     DOI: 10.1007/s10151-015-1381-7

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  21 in total

1.  Incidence and aetiological factors in pilonidal sinus among Turkish soldiers.

Authors:  O F Akinci; M Bozer; A Uzunköy; S A Düzgün; A Coşkun
Journal:  Eur J Surg       Date:  1999-04

2.  [Treatment of pilonidal sinus with excision and primary suture using a local, resorbable antibiotic carrier. Results of a prospective randomized study].

Authors:  P Vogel; J Lenz
Journal:  Chirurg       Date:  1992-09       Impact factor: 0.955

3.  Cost effectiveness of local collagen-gentamicin as prophylaxis for sternal wound infections in different risk groups.

Authors:  Orjan Friberg; Lars-Göran Dahlin; Lars-Ake Levin; Anders Magnusson; Hans Granfeldt; Jan Källman; Rolf Svedjeholm
Journal:  Scand Cardiovasc J       Date:  2006-04       Impact factor: 1.589

4.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Int J Surg       Date:  2010-02-18       Impact factor: 6.071

5.  Effect of gentamicin-absorbed collagen in wound healing in pilonidal sinus surgery: a prospective randomized study.

Authors:  I Yetim; O V Ozkan; A Dervişoglu; K Erzurumlu; E Canbolant
Journal:  J Int Med Res       Date:  2010 May-Jun       Impact factor: 1.671

6.  Local administration of antibiotics by gentamicin-collagen sponge does not improve wound healing or reduce recurrence rate after pilonidal excision with primary suture: a prospective randomized controlled trial.

Authors:  Roland E Andersson; Gudrun Lukas; Stefan Skullman; Anders Hugander
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

Review 7.  Pilonidal disease.

Authors:  Tracy L Hull; James Wu
Journal:  Surg Clin North Am       Date:  2002-12       Impact factor: 2.741

8.  A prospective randomised study comparing two treatment modalities for chronic pilonidal sinus with a 5-year follow-up.

Authors:  Milind M Rao; Wojtek Zawislak; Raymond Kennedy; Robert Gilliland
Journal:  Int J Colorectal Dis       Date:  2009-10-13       Impact factor: 2.571

9.  Bactericidal antimicrobial cover in primary suture of perianal or pilonidal abscess. A prospective, randomized, double-blind clinical trial.

Authors:  E Lundhus; P Gjøde; F Gottrup; C N Holm; S Terpling
Journal:  Acta Chir Scand       Date:  1989 Jun-Jul

10.  Patient characteristics and symptoms in chronic pilonidal sinus disease.

Authors:  K Søndenaa; E Andersen; I Nesvik; J A Søreide
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

View more
  5 in total

Review 1.  Management of sacrococcygeal pilonidal sinus disease.

Authors:  Rhiannon L Harries; Abdullah Alqallaf; Jared Torkington; Keith G Harding
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

Review 2.  A mapping review of sacrococcygeal pilonidal sinus disease.

Authors:  M Kumar; W H Clay; M J Lee; S R Brown; D Hind
Journal:  Tech Coloproctol       Date:  2021-03-16       Impact factor: 3.781

3.  The risk of recurrence of Pilonidal disease after surgical management.

Authors:  Feras M Almajid; Abdullah A Alabdrabalnabi; Khalifa Abdulaziz Almulhim
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

4.  Surgical procedures in the pilonidal sinus disease: a systematic review and network meta-analysis.

Authors:  Siwei Bi; Kaibo Sun; Shanshan Chen; Jun Gu
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

5.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of pilonidal disease.

Authors:  R Perinotti; G Gallo; M Milone; L Basso; M Manigrasso; R Pietroletti; A Bondurri; M La Torre; G Milito; M Pozzo; D Segre
Journal:  Tech Coloproctol       Date:  2021-06-27       Impact factor: 3.781

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.